Regulatory Story
Omega Diagnostics Group PLC - ODX Allersys Distribution Agreement Released 07:00 20-Apr-2018
RNS Number : 5374L
Omega Diagnostics Group PLC 20 April 2018
Omega Diagnos�cs Group PLC ("Omega" or "the Company" or the "Group")
Allersys Distribu�on Agreement
Omega (AIM: ODX), the medical diagnos�cs company focused on allergy, food intolerance and infec�ous disease, announces that it has signed a global distribu�on agreement with Immunodiagnos�c Systems Limited ("IDS") for its Allersys® range of allergy assays.
The partnership with IDS is a long-term supply agreement and the Company now looks forward to working with IDS to introduce the ini�al launch panel of 51 allergy tests into the market.
Omega will con�nue to develop new assays to provide regular updates to the IDS instrument menu to increase its compe��veness by offering a broader range of tests.
Colin King, CEO of Omega commented: "I am pleased that we have finally concluded a deal with IDS to become our exclusive distributor for our Allersys® product range. Whilst we expect modest sales growth in the short term as we work together to further expand our menu, we are excited that with our development capability and IDS instrument and commercial exper�se we can make a significant difference within the Allergy tes�ng market. We believe our product offers a more flexible and efficient work-flow solu�on for small to mid-size laboratories."
The informa�on communicated in this announcement is inside informa�on for the purposes of Ar�cle 7 of EU Regula�on 596/2014.
Contacts:
Omega Diagnos�cs Group PLC Colin King, Chief Execu�ve
Tel: 01259 763 030www.omegadiagnos�cs.com
Kieron Harbinson, Group Finance DirectorfinnCap Ltd
Tel: 020 7220 0500
Geoff Nash/James Thompson (Corporate Finance)
Camille Gochez/ Abigail Wayne (Corporate Broking)
Walbrook PR Limited
Tel: 020 7933 8780 oromega@walbrookpr.com
Paul McManus Lianne Cawthorne
Mob: 07980 541 893 Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRUKOWRWSASAAR
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries.Terms and conditions, including restrictions on use and distribution apply.
©2014 London Stock Exchange plc. All rights reserved
Allersys Distribution Agreement - RNS
Attachments
- Original document
- Permalink
Disclaimer
Omega Diagnostics Group plc published this content on 20 April 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 20 April 2018 11:36:10 UTC